Panbela Therapeutics Granted New Japanese Patent for Novel Process for the Production of SBP-101
- ByInvesting.com-
Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical-stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, today announced...